Ophthalmic apraclonidine use in children may cause serious systemic events Children aged 6 years or younger given apraclonidine ophthalmic drops may be at high risk for developing serious central nervous system and cardiorespiratory adverse events.

#MedNews - Children aged 6 years or younger given #apraclonidine ophthalmic drops may be at high risk for developing serious central nervous system and cardiorespiratory adverse events.

Full story 👉 buff.ly/aG2Rbbh

#EyeSky #PediatricMed